LGVN · Longeveron Inc.
$0.74
+0.04 (+6.06%)
At close · Aug 14
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company has prepared a cash flow forecast which indicates that it does not have sufficient cash to meet its minimum expenditure commitments for one year from the date these financial statements are available to be issued and therefore needs to raise additional funds to continue as a going concern. As a result, there is substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 12, 2026
Market Cap
$23.59M
Shares
31.88M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2026-03-25 | New | Biotechnology | $33,515,000 | $15,890,000 | 06b |
| 2024-07-23 | New | Biotechnology | $9,508,010 | $0 | 06b |
| 2024-06-25 | New | Biotechnology | $9,444,516 | $0 | 06b |
| 2024-04-25 | New | Biotechnology | $12,424,674 | $0 | 06b |
| 2024-01-08 | New | Biotechnology | $2,571,942 | $0 | 06b |
| 2023-10-24 | New | Biotechnology | $8,350,001 | $0 | 06b |
| 2021-12-13 | New | Biotechnology | $20,462,545 | $20,462,545 | 06b |
| 2020-02-06 | New | Biotechnology | $25,000,000 | $100,000 | 06b |
| 2020-02-06 | Amendment | Biotechnology | $25,000,000 | $954,970 | 06b |
Showing 1–9 of 9 filings
Key facts
CIK
1721484
CUSIP
54303L203
13F (30d)
36 filings
36 filers
Visit website
Investor relations